Catalight, the Walnut Creek-based nonprofit that operates one of the largest behavioral health networks in the country, announced a partnership today with Frontera Health, a Denver-based startup using artificial intelligence to streamline autism care. The deal positions Catalight to deploy Frontera’s technology across its network of more than 16,000 practitioners serving some 24,000 patients and families annually.

The partnership arrives at an interesting moment for Catalight. Recently, the organization’s research arm published a peer-reviewed study in the Journal of Autism and Developmental Disorders that found limited evidence supporting high-intensity ABA therapy, the 30-to-40-hour-per-week model that has long dominated the field. The new technology partnership, in other words, is not merely about efficiency. It is about operationalizing a fundamentally different philosophy of care.

Under the agreement, Catalight will integrate Frontera’s AI tools for clinical assessment and documentation, parent-mediated care delivery, and practitioner training through its newly expanded Catalight Academy. The technology is designed to reduce the administrative burden on board certified behavior analysts, or BCBAs, who often spend as much time on paperwork as on direct patient care.

“Services today are often driven by quantity over quality,” said Tracy Gayeski, Catalight’s Chief Health Officer. “The system today for many is too hard to navigate, too slow to diagnose and treat, and costs too much with little evidence of effectiveness.”

Dimeil Ushana, Frontera’s Chief Commercial Officer, echoed that assessment. “Autism care as a system wasn’t really designed for scale, for urgency, and to actually service the complexity that families face today,” he said. “We believe that families deserve answers quickly, clearer pathways to care, and services that yield outcomes.”

A VC-Backed Bet on Rural Access

Frontera emerged from stealth in February 2025 with $32 million in seed funding, a substantial sum co-led by Lux Capital and Lightspeed Venture Partners, with participation from Bison Ventures, Menlo Ventures, and Inspired Capital. The company is led by Amol Deshpande, a former partner at Kleiner Perkins who was the first investor in Beyond Meat and later co-founded Farmers Business Network, an agricultural technology company once valued at nearly $4 billion.

Deshpande’s interest in autism care is personal: he is the parent of a son with autism. “As a parent, I saw firsthand how challenging the system is for clinicians,” he said in a statement. “Faster diagnoses and accelerated care lead directly to better outcomes later in life.”

Frontera’s suite of AI tools includes a Diagnosis Builder and an Assessment Builder, which the company says can reduce report-writing time from eight to ten hours down to two or three. The company has also developed what it calls “digital phenotyping,” a video analysis technology trained by clinicians to track patient interactions and behaviors at 30 frames per second. Frontera has piloted its technology at its own clinics in New Mexico and Colorado.

“It’s really about empowering clinicians to do their job better at the top of their license,” Ushana said. “Our technology removes some of the friction points they encounter every day—things that are probably more correlated to time and process—so they can focus on what they’re best at, which is providing care to patients.”

The Parent-Mediated Care Connection  

The emphasis on “parent-mediated care” in the partnership announcement aligns with Catalight’s 2024 practice guidelines, which recommended no more than 15 hours per week of direct therapy for most cases, with a significant role for caregiver coaching. Such models depend on parents or caregivers implementing strategies at home, which requires robust training and support, but dramatically fewer billable clinician hours.

“The parent-mediated model drives parents toward further engaging in the actual care that is delivered to their child,” Ushana said. “When you look at it more broadly, there’s an augmentation of supply, because you start to create an engaged population that is also working alongside providers to make sure that care is being delivered effectively.”

For an industry grappling with workforce shortages and rising costs, the appeal is obvious. Whether AI-augmented, lower-intensity care can deliver equivalent or superior outcomes to traditional high-hour models remains an open research question, one that Catalight’s own researchers are actively investigating.

“Catalight has some of the most rigorous clinical standards in the industry,” Deshpande said. “Their selection of Frontera reflects our model and technology as we strive to better serve clinicians, improve the quality of care, and reduce costs for families.”

Ushana put it more bluntly: “Autism care as an ecosystem is ready for transformation. This partnership brings complementary strengths from technology and clinical to start delivering high-quality autism care at scale—and that’s better for all stakeholders involved: families, clinicians, and health plans.”

Catalight operates its network through affiliate partners including Easterseals Hawaii and Easterseals Northern California. Terms of the partnership were not disclosed.